StockDuty ← Dashboard Aug 14, 2026 08:45 PM ET
CatalystMacro

ELITE OUTLINES 2028 ANTICOAGULANT LAUNCH TARGET AS NASDAQ UPLISTING PROGRESSES - SEEKINGALPHA

Uplisting catalyst plus 2028 launch target signals regulatory and market milestones.

What changed
Why it matters
Uplisting catalyst plus 2028 launch target signals regulatory and market milestones.
Sources
seekingalpha
Related signals
STOCKS BOUNCE BACK FROM FED SELLOFF, NASDAQ SNAPS 6-DAY LOSING STREAK: LIVE UPDATES - CNBC →SOUTH KOREA’S SK HYNIX RAISES $26.5BN IN RECORD-BREAKING US IPO - ALJAZEERA →CAN CHINA FLASH MEMORY GIANT YMTC SMASH SHANGHAI STAR MARKET IPO RECORDS ? →